SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-096017
Filing Date
2018-03-26
Accepted
2018-03-26 16:38:06
Documents
4
Period of Report
2018-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d559748d8k.htm 8-K 22646
2 EX-99 d559748dex99.htm EX-99 8523
3 GRAPHIC g559748g0327001129858.jpg GRAPHIC 2477
4 GRAPHIC g559748g0327001129952.jpg GRAPHIC 1964
  Complete submission text file 0001193125-18-096017.txt   38876
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 18713137
SIC: 2834 Pharmaceutical Preparations